Author: Claudia Patricia Moreno Alzate

May 29, 2023 The Company has products in various stages of testing and sales with more than 40 customers in 11 countries, with continued growth expected for the year. Q1 2023 revenue of $786,498; Adjusted EBITDA loss of $1.9 million. PharmaCielo continues to focus on

May 16, 2023 Represents PharmaCielo’s first shipment to South Africa, which has well-established export networks in the UK and Australia, and other potential markets, globally. TORONTO, Canada and RIONEGRO, Colombia (May 16, 2023) – PharmaCielo Ltd. (“PharmaCielo” or the “Company”) (TSXV: PCLO, OTCQX: PCLOF), the